Oncobiologics Inc. Series A Warrant (OTLKW) Key Ratios
$0.03
As on 16-Feb-2022 14:29EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | 74.58 | 7.34 | 99.76 | -167.39 | -9.63 |
| Net Profit | 72.80 | -0.05 | 99.74 | -79.34 | -9.64 |
| EPS | 72.80 | -0.05 | 99.74 | -1.44 | 10.00 |
| Book Value | -- | -- | 63.02 | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Sep-21 | Sep-20 |
| EBIT-Margin
| -261.77 | -776.34 | -- | -- | -100.42 |
| Net Margin
| -- | -- | 13,399.90 | -- | -- |
| Return on equity
| 295,341.15 | 177,294.23 | -301.85 | -1,430.33 | 887,235.14 |
| Return on Capital
| -30,623.21 | -18,189.19 | -- | -107.89 | -92,055.30 |
| Return on Assets
| -187.04 | -196.33 | -0.83 | -0.58 | -385.38 |
| Debt to Equity (x)
| -- | -- | 0.20 | 2.40 | 28.33 |
The underlying data is unavailable.